ROBERT GILLESPIE: Open Payments
NPI 1922026467 · BLACKFOOT, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 38 payments from 7 companies in 2025. Trend: 2023 $82 · 2024 $364 · 2025 $864
Food & beverage: $864
| Company | Payments | Amount |
|---|---|---|
| Organogenesis Inc. | 16 | $360 |
| Kerecis Limited | 11 | $235 |
| MIMEDX Group, Inc. | 4 | $96 |
| Reprise Biomedical, Inc. | 3 | $95 |
| Solventum Corporation | 2 | $29 |
| ABBVIE INC. | 1 | $28 |
| Smith+Nephew, Inc. | 1 | $21 |
Products named: Kerecis SurgiClose, APLIGRAF, Miro3D, NOVACHOR, NUSHIELD, SIMPLIMAX, AFFINITY, ACTIV.A.C..
Industry payments across ID — which companies pay providers there.
